In November, Gilead achieved top-line results from two Phase III trials (SIMPLIFY 1 and 2) that evaluated momelotinib, an investigational inhibitor of Janus kinase (JAK) compared to ruxolitinib or best alternative therapy (BAT) in myelofibrosis, a relatively rare bone marrow cancer
Short-term, non-benzodiazepine anxiolytics to manage taper-related anxiety
Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH
Such modifications also reduce enzymatic degradation rates, thereby prolonging the metabolic half-life of flavonoids within the body (Lee et al., 2016)
I tend to mount the charger on top of the Teensy, so that I can mount the Teensy flat on a PCB or breadboard
El rol de las patentes y la exclusividad de mercado Cuando un laboratorio desarrolla un medicamento innovador, obtiene una patente que le otorga el derecho exclusivo de comercializarlo durante aproximadamente 20 aos desde la fecha de solicitud inicial
